Evidence map›Paper›PMID 33722935›Full record

ArticleGenome research2021

Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data.

Matthew D Parker, Benjamin B Lindsey, Shay Leary, Silvana Gaudieri, Abha Chopra, Matthew Wyles, Adrienn Angyal, Luke R Green, Paul Parsons, Rachel M Tucker and 24 more

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. sgRNAs: A SARS-CoV-2 emerging issue.Aspects of molecular medicine · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 4 institutions in 3 countries.

Matthew D Parker *Sheffield Bioinformatics Core, The University of Sheffield, Sheffield S10 2HQ, United Kingdom.ORCID 0000-0003-2999-3870
Benjamin B Lindsey *Sheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.ORCID 0000-0003-4227-2592
Shay LearyInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch WA 6150, Western Australia, Australia.ORCID 0000-0002-6966-2294
Silvana GaudieriInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch WA 6150, Western Australia, Australia.
Abha ChopraInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch WA 6150, Western Australia, Australia.ORCID 0000-0001-5008-9080
Matthew WylesSheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield S10 2HQ, United Kingdom.
Adrienn AngyalThe Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.ORCID 0000-0001-8483-1749
Luke R GreenThe Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.ORCID 0000-0002-2836-2041
Paul ParsonsDepartment of Animal and Plant Sciences, The University of Sheffield, Sheffield S10 2TN, United Kingdom.
Rachel M TuckerDepartment of Animal and Plant Sciences, The University of Sheffield, Sheffield S10 2TN, United Kingdom.
Rebecca BrownThe Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.
Danielle GrovesThe Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.
Katie JohnsonSheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.
Laura CarrileroDepartment of Animal and Plant Sciences, The University of Sheffield, Sheffield S10 2TN, United Kingdom.
Joe HefferIT Services, The University of Sheffield, Sheffield S10 2FN, United Kingdom.
David G PartridgeSheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.
Cariad EvansSheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.
Mohammad RazaSheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.
Alexander J KeeleySheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.
Nikki SmithThe Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.
Ana Da Silva FilipeCentre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.ORCID 0000-0002-9442-2903
James G ShepherdCentre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.ORCID 0000-0003-3915-048X
Chris DavisCentre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.
Sahan BennettCentre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.
Vattipally B SreenuCentre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.ORCID 0000-0001-6673-4697
Alain KohlCentre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.
Elihu Aranday-CortesCentre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.ORCID 0000-0003-2637-2307
Lily TongCentre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.
Jenna NicholsCentre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.ORCID 0000-0003-0093-7170
Emma C ThomsonCentre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.ORCID 0000-0003-1482-0889
COVID-19 Genomics UK (COG-UK) Consortium
Dennis WangSheffield Bioinformatics Core, The University of Sheffield, Sheffield S10 2HQ, United Kingdom.ORCID 0000-0003-0068-1005
Simon MallalInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch WA 6150, Western Australia, Australia.ORCID 0000-0002-7036-1309
Thushan I de SilvaSheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.ORCID 0000-0002-6498-9212
University of Sheffield · GBMRC University of Glasgow Centre for Virus Research · GBSheffield Teaching Hospitals NHS Foundation Trust · GBMurdoch University · AU

Funding

Medical Research Council MC_PC_19027Medical Research Council MC_UU_12014/12Medical Research Council MC_UU_12014/8Wellcome Trust
6 · The paper itself

Abstract

We have developed periscope, a tool for the detection and quantification of subgenomic RNA (sgRNA) in SARS-CoV-2 genomic sequence data. The translation of the SARS-CoV-2 RNA genome for most open reading frames (ORFs) occurs via RNA intermediates termed "subgenomic RNAs." sgRNAs are produced through discontinuous transcription, which relies on homology between transcription regulatory sequences (TRS-B) upstream of the ORF start codons and that of the TRS-L, which is located in the 5' UTR. TRS-L is immediately preceded by a leader sequence. This leader sequence is therefore found at the 5' end of all sgRNA. We applied periscope to 1155 SARS-CoV-2 genomes from Sheffield, United Kingdom, and validated our findings using orthogonal data sets and in vitro cell systems. By using a simple local alignment to detect reads that contain the leader sequence, we were able to identify and quantify reads arising from canonical and noncanonical sgRNA. We were able to detect all canonical sgRNAs at the expected abundances, with the exception of ORF10. A number of recurrent noncanonical sgRNAs are detected. We show that the results are reproducible using technical replicates and determine the optimum number of reads for sgRNA analysis. In VeroE6

Indexed as

Genome, ViralAnimalsBase SequenceChlorocebus aethiopsHumansLimit of DetectionRNA, ViralSARS-CoV-2Sequence Analysis, RNAVero CellsRNA, Viral

Identifiers

PMID33722935
PMCPMC8015849
OpenAlexW3136850423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.